Drugs / vnacicizumab
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06770088 Comparator | Jan 2025 → Jan 2026 overdue | spondyloarthropathy | Sun Yat-sen University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | vnacicizumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06770088 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT06770088 ↗ |